This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Goudie, A. J. Articles by Halford, J. C. G. Search for Related Content PubMed PubMed Citation Articles by Goudie, A. J. Articles by Halford, J. C. G. Social Bookmarking                         What's this?

Characterization of olanzapine-induced weight gain in rats

Judith A. Smith

Jason C. G. Halford

Psychology Department, Eleanor Rathbone Building, Liverpool University, Liverpool, UK

Novel antipsychotic drugs (APDs) have enhanced therapeutic actions compared to ‘typical’ APDs. However,clinical studies indicate that some induce marked weight gain. We attempted to model this effect in female Wistar rats given olanzapine chronically at 4 mg/kg b.i.d (4.5 h between injections). Such rats showed marked weight gain, which was statistically significant after only a single day of treatment, although weight gain increased up to a plateau after 10 days of treatment. Cessation of treatment led to rapid weight loss, which was significant after a single day of withdrawal. The weight gain observed was characterized by marked individual differences. As some clinical reports suggest that novel APD-induced weight gain is most pronounced in patients with the lowest body weight, we examined the relationship between weight gain and baseline body weight. However, we observed no significant relationship between baseline body weight and weight gain. The observation that olanzapine can induce weight gain rapidly in rats, in conjunction with the observation of marked individual differences in weight gain, suggests that patients at risk of developing weight gain might be detectable early in treatment. Furthermore, the finding that weight gain is rapidly reversible suggests that patients at risk of weight gain could be switched to APDs with less pronounced tendencies to induce weight gain. The study of APD-induced weight gain in rodents may provide insights into the nature, causes, and treatments for, novel APD-induced weight gain in the clinic. However, it remains to be determined how closely rodent models mimic the clinical situation and whether the mechanism(s) involved in the weight gain we have observed are the same as those involved in the clinical use of these drugs.

Key Words: atypical antipsychotics • clozapine • individual differences • mice • obesity • olanzapine • rats • side-effects • weight • gain

Journal of Psychopharmacology, Vol. 16, No. 4, 291-296 (2002)
DOI: 10.1177/026988110201600402


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. Coccurello, A. Caprioli, R. Conti, O. Ghirardi, F. Borsini, P. Carminati, and A. Moles Olanzapine (LY170053, 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] Benzodiazepine), but Not the Novel Atypical Antipsychotic ST2472 (9-Piperazin-1-ylpyrrolo[2,1-b][1,3]benzothiazepine), Chronic Administration Induces Weight Gain, Hyperphagia, and Metabolic Dysregulation in Mice J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 905 - 911. [Abstract] [Full Text] [PDF]

				S. Snigdha, C. Thumbi, G. Reynolds, and J. Neill Ziprasidone and aripiprazole attenuate olanzapine-induced hyperphagia in rats J Psychopharmacol, July 1, 2008; 22(5): 567 - 571. [Abstract] [PDF]

				M. Fell, J. Neill, N. Anjum, L. Peltola, and K. Marshall Investigation into the influence of a high fat diet on antipsychotic-induced weight gain in female rats J Psychopharmacol, March 1, 2008; 22(2): 182 - 186. [Abstract] [PDF]

				G.D. Cooper, L.C. Pickavance, J.P.H. Wilding, J.A. HarroLd, J.C.G. HaLford, and A.J. Goudie Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities J Psychopharmacol, June 1, 2007; 21(4): 405 - 413. [Abstract] [PDF]

				M. J. Fell, K. M. Marshall, J. Williams, and J. C. Neill Effects of the Atypical Antipsychotic Olanzapine on Reproductive Function and Weight Gain in Female Rats J Psychopharmacol, June 1, 2004; 18(2): 149 - 155. [Abstract] [PDF]